Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

722 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.
Hyams C, Marlow R, Maseko Z, King J, Ward L, Fox K, Heath R, Tuner A, Friedrich Z, Morrison L, Ruffino G, Antico R, Adegbite D, Szasz-Benczur Z, Garcia Gonzalez M, Oliver J, Danon L, Finn A. Hyams C, et al. Among authors: heath r. Lancet Infect Dis. 2021 Nov;21(11):1539-1548. doi: 10.1016/S1473-3099(21)00330-3. Epub 2021 Jun 23. Lancet Infect Dis. 2021. PMID: 34174190 Free PMC article.
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study.
Hyams C, Challen R, Begier E, Southern J, King J, Morley A, Szasz-Benczur Z, Gonzalez MG, Kinney J, Campling J, Gray S, Oliver J, Hubler R, Valluri S, Vyse A, McLaughlin JM, Ellsbury G, Maskell NA, Gessner BD, Danon L, Finn A; Avon CAP Research Group. Hyams C, et al. Lancet Reg Health Eur. 2022 Oct;21:100473. doi: 10.1016/j.lanepe.2022.100473. Epub 2022 Aug 8. Lancet Reg Health Eur. 2022. PMID: 35965672 Free PMC article.
Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control study.
Chatzilena A, Hyams C, Challen R, Marlow R, King J, Adegbite D, Kinney J, Clout M, Maskell N, Oliver J, Danon L, Finn A; Avon CAP Research Group. Chatzilena A, et al. Lancet Reg Health Eur. 2022 Dec 7;25:100552. doi: 10.1016/j.lanepe.2022.100552. eCollection 2023 Feb. Lancet Reg Health Eur. 2022. PMID: 36506791 Free PMC article.
Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom.
Hyams C, Challen R, Marlow R, Nguyen J, Begier E, Southern J, King J, Morley A, Kinney J, Clout M, Oliver J, Gray S, Ellsbury G, Maskell N, Jodar L, Gessner B, McLaughlin J, Danon L, Finn A; AvonCAP Research Group. Hyams C, et al. Lancet Reg Health Eur. 2023 Feb;25:100556. doi: 10.1016/j.lanepe.2022.100556. Epub 2022 Dec 12. Lancet Reg Health Eur. 2023. PMID: 36530491 Free PMC article.
Parapneumonic effusions related to Streptococcus pneumoniae: serotype and disease severity trends from 2006 to 2018 in Bristol, UK.
Hyams C, Arnold DT, Heath R, Amin-Chowdhury Z, Hettle D, Ruffino G, North P, Grimes C, Fry NK, Williams P, Challen R, Danon L, Williams OM, Ladhani S, Finn A, Maskell N. Hyams C, et al. Among authors: heath r. BMJ Open Respir Res. 2023 May;10(1):e001440. doi: 10.1136/bmjresp-2022-001440. BMJ Open Respir Res. 2023. PMID: 37147024 Free PMC article.
Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus pneumoniae Infection, Bristol and Bath, UK, 2006‒2022.
Hyams C, Challen R, Hettle D, Amin-Chowdhury Z, Grimes C, Ruffino G, Conway R, Heath R, North P, Malin A, Maskell NA, Williams P, Williams OM, Ladhani SN, Danon L, Finn A. Hyams C, et al. Among authors: heath r. Emerg Infect Dis. 2023 Oct;29(10):1953-64. doi: 10.3201/eid2910.230519. Emerg Infect Dis. 2023. PMID: 37735739 Free PMC article. Review.
722 results